Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Cardinal Health Inc (CAH)

NYSE
Currency in USD
122.84
-2.40(-1.92%)
Closed
After Hours
122.840.00(0.00%)
CAH Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
121.15125.24
52 wk Range
93.17126.23
Key Statistics
Edit
Prev. Close
125.24
Open
124.6
Day's Range
121.15-125.24
52 wk Range
93.17-126.23
Volume
2.4M
Average Volume (3m)
2.07M
1-Year Change
16.89%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CAH Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
126.75
Upside
+3.18%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 36 consecutive years
Show more

Cardinal Health Inc Company Profile

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Employees
48411

Cardinal Health Inc SWOT Analysis


Specialty Push
Cardinal Health's acquisition of ION for $1.115B signals a shift to offensive strategies, potentially accelerating its specialty oncology services growth
Financial Resilience
Strong Q1 FY2025 results led to raised EPS guidance, with pharmaceutical segment outperforming despite loss of Optum business
Segment Divergence
Explore the contrast between thriving pharmaceutical and specialty segments versus challenges in Global Medical Products Distribution
Analyst Outlook
Price targets range from $107 to $133, with an average of $118.50, reflecting varied perspectives on Cardinal Health's growth potential
Read full SWOT analysis
CAH Full Pro Research
Institutional-Grade Stock Analysis
Understand how CAH earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks

Cardinal Health Inc Earnings Call Summary for Q4/2024

  • Cardinal Health raises EPS guidance to $7.75-$7.90 and adjusted free cash flow forecast to $1-$1.5 billion
  • 16% profit increase in Pharma and Specialty Solutions segment; total revenue down 4% to $52 billion
  • Announced $1.1 billion acquisition of Integrated Oncology Network, expected to close by year-end
  • GMPD segment profits dropped to $8 million due to unexpected costs; facing increased tariffs on Chinese-sourced products
  • Strong demand for GLP-1 drugs and 20%+ growth in theranostics and at-home solutions; COVID-19 vaccine revenue growth forecast at 18-20%
Last Updated: 2024-11-01, 04:14 p/m
Read Full Transcript

Compare CAH to Peers and Sector

Metrics to compare
CAH
Peers
Sector
Relationship
P/E Ratio
23.2x6.8x−0.7x
PEG Ratio
0.040.010.00
Price/Book
−9.1x2.3x2.6x
Price / LTM Sales
0.1x2.0x3.2x
Upside (Analyst Target)
3.8%23.5%45.9%
Fair Value Upside
Unlock40.0%7.6%Unlock

Analysts' Recommendations

5 Buy
10 Hold
2 Sell
Ratings:
15 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 126.75

(+3.18% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.26
Dividend Yield
1.61%
Industry Median 1.74%
Annualized payout
2.0224
Paid quarterly
5-Years Growth
+1.00%
Growth Streak

People Also Watch

204.23
ALL
-0.35%
84.93
SWK
-1.28%
127.29
PRU
+1.10%
57.16
WMB
+1.53%
132.61
WELL
-0.73%

FAQ

What Is the Cardinal Health (CAH) Stock Price Today?

The Cardinal Health stock price today is 122.84

What Stock Exchange Does Cardinal Health Trade On?

Cardinal Health is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Cardinal Health?

The stock symbol for Cardinal Health is "CAH."

Does Cardinal Health Pay Dividends? What’s The Current Dividend Yield?

The Cardinal Health dividend yield is 1.65%.

What Is the Cardinal Health Market Cap?

As of today, Cardinal Health market cap is 29.81B.

What is Cardinal Health Earnings Per Share?

The Cardinal Health EPS is 5.26.

What Is the Next Cardinal Health Earnings Date?

Cardinal Health will release its next earnings report on Jan 30, 2025.

From a Technical Analysis Perspective, Is CAH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.